News | Latest Breaking News Stories & Headlines

ReActiv8 is a device Mainstay Medical has developed to treat chronic lower back pain

Mainstay Medical raises $108m in equity financing

Medical device company Mainstay Medical has closed an equity financing in which it raised gross proceeds of $108m.

ReActiv8 is a device Mainstay has developed to treat chronic lower back pain

US FDA approves Mainstay Medical's ReActiv8 product

Dublin-headquartered medical device company Mainstay Medical said today that the US Food and Drug Administration (FDA) has approved its Premarket Approval (PMA) application for its ...

Business • 22 Jun 20

Mainstay Medical gets boost from Down Under

Dublin listed medical device company Mainstay Medical has received regulatory approval from the Australian Therapeutic Goods Administration (TGA) for its ReActiv8 device.

Business • 06 Dec 19

Mainstay Medical's chief executive Jason Hannon said the company goals for the next two years are clear

Mainstay Medical raises €30m through share placing

Medical devices company Mainstay Medical has raised €30.1m through a new share placing as it seeks to launch its back pain product in Germany and ...

Business • 15 Feb 18

Jason Hannon takes up the top job at Mainstay Medical today

Hannon takes on CEO role at Mainstay Medical

Jason Hannon has today taken up his role as chief executive at medical device company Mainstay Medical.

Business • 09 Oct 17

Mainstay Medical reported revenues of $0.25m for the six months to the end of June

Mainstay Medical names Hannon as new CEO

Medical device company Mainstay Medical has said that Jason Hannon will succeed Peter Crosby as its chief executive officer with effect from next month.

Business • 06 Sep 17

Mainstay Medical's half yearly operating expenses and losses mount

Mainstay Medical's half yearly losses rise

Mainstay Medical has reported a loss before tax of $8.8m for the six months to the end of June, up from a figure of $6.3m ...

Business • 22 Sep 16

Mainstay's ReActiv8 product is seen as a potential breakthrough treatment for chronic back pain

Mainstay enrolls first subject for clinical trial

Mainstay Medical, the Dublin-based medical devices firm, said it has enrolled the first subject in its ReActiv8-B clinical trial.

Business • 14 Sep 16

Mainstay Medical is looking to bring to market a product to treat chronic back pain

Mainstay Medical raises €30m in share placing

Mainstay Medical, a medical device company, has raised €30m through a placing of shares with both new and existing shareholders.

Business • 17 Jun 16

There are over two million people in the US and EU who could be candidates for treatment with ReActiv8

Positive results for Mainstay's ReActiv8 confirmed

Mainstay Medical has said the latest results from trials on its ReActiv8 product continue to show clinically important, statistically significant and lasting improvement in pain, ...

Business • 04 Dec 15

Mainstay Medical says over two million people in the US and EU could be candidates for treatment with ReActiv8

Mainstay Medical applies for CE mark for ReActiv8

Dublin-listed medical devices firm Mainstay Medical has applied for a CE mark for its ReActiv8 product, an implantable neurostimulation system to treat chronic low back ...

Business • 02 Nov 15

Mainstay Medical is developing an implant to help people with chronic back pain.

Positive results from Mainstay Medical's trial

Mainstay Medical has said that its operating expenses related to on-going activities were $6.3m for the six months to the end of June 2015.

Business • 31 Aug 15

Search RTÉ.ie

Cant find what you're looking for?